Cargando…

Ruxolitinib: Immunosuppression leading to impaired viral RNA clearance: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233623/ http://dx.doi.org/10.1007/s40278-021-98094-5

Ejemplares similares

Immunosuppressants: Covid-19 pneumonia and delayed viral clearance: case report
Publicado: (2021)

Ruxolitinib: Viral respiratory infections: case report
Publicado: (2019)

Hydroxychloroquine/immunosuppressants: Delayed viral clearance, drug interaction and off label use: 3 case reports
Publicado: (2021)

Immunosuppressants: Lymphopenia, neutropenia and prolongation of the coronavirus disease 2019 (COVID-19) viral clearance: case report
Publicado: (2021)

Ruxolitinib: Thrombocytopenia following compassionate use of ruxolitinib: 2 case reports
Publicado: (2022)

Abatacept/immunosuppressants/ruxolitinib: Various toxicities following off-label use and lack of efficacy: 20 case reports
Publicado: (2022)

Ruxolitinib: Extreme thrombocytosis: case report
Publicado: (2021)

Dexamethasone misuse: Delayed viral clearance leading to severe COVID-19 pneumonia: case report
Publicado: (2021)

Ruxolitinib Treatment During Myelofibrosis Leads to Cutaneous Mycobacterium marinum Infection: A Case Report
por: Chen, Xiaonan, et al.
Publicado: (2023)

Unexpected Neurological Symptoms of Ruxolitinib: A Case Report
por: Furia, Francesca, et al.
Publicado: (2020)

Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
por: Pálmason, Róbert, et al.
Publicado: (2015)

Ruxolitinib found to cause eyelash growth: a case report
por: Song, Julia, et al.
Publicado: (2017)

Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib
por: Elli, Elena Maria, et al.
Publicado: (2019)

Precision treatment of Singleton Merten syndrome with ruxolitinib: a case report
por: Broser, Philip, et al.
Publicado: (2022)

Methylprednisolone/prednisolone/ruxolitinib: Masked fever and lack of efficacy: case report
Publicado: (2022)

Multiple drugs: Off-label use and prolonged viral clearance: case report
Publicado: (2021)

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
por: Maffini, Enrico, et al.
Publicado: (2016)

Cryptococcal infection with ruxolitinib in primary myelofibrosis: A case report and literature review
por: Ciochetto, Zachary, et al.
Publicado: (2022)

Dexamethasone/methylprednisolone: Prolongation of the coronavirus disease 2019 viral clearance time: case report
Publicado: (2021)

Hydroxychloroquine/methylprednisolone/nafamostat: Delayed viral clearance and off label use: case report
Publicado: (2021)

Methylprednisolone/prednisolone: Delayed viral clearance and off label use: 2 case reports
Publicado: (2020)

Ruxolitinib: Rebound effect manifested as acute hypoxaemic respiratory failure: 3 case reports
Publicado: (2021)

Ruxolitinib: Grade 3 liver toxicity following off-label use: case report
Publicado: (2020)

Widespread sebaceous neoplasms in the setting of chronic immunosuppression with near-complete clearance on isotretinoin
por: El-Behaedi, Salma, et al.
Publicado: (2022)

Topical ruxolitinib for the treatment of granuloma faciale
por: Wong, Alan, et al.
Publicado: (2023)

Ruxolitinib cream for the treatment of cutaneous sarcoidosis
por: Smith, Jeffrey S., et al.
Publicado: (2023)

A case report of disseminated histoplasmosis and concurrent cryptococcal meningitis in a patient treated with ruxolitinib
por: Prakash, Katya, et al.
Publicado: (2019)

Delayed granulomatous eruption of the nose associated with ruxolitinib
por: Brown, Margaret, et al.
Publicado: (2020)

Treatment of cutaneous lupus with topical ruxolitinib cream
por: Park, Jonathan J., et al.
Publicado: (2022)

Ruxolitinib for severe fever with thrombocytopenia syndrome (SFTS)
por: Wen, Sai, et al.
Publicado: (2022)

Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report
por: Aylı, Meltem, et al.
Publicado: (2015)

Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report
por: Wang, Lina, et al.
Publicado: (2023)

Hepatocellular carcinoma in Hepatitis C genotype 4 after viral clearance and in absence of cirrhosis: two case reports
por: Derbala, Moutaz, et al.
Publicado: (2009)

A Case of Hepatitis E Persistence in a Patient With Myelofibrosis Under Ruxolitinib
por: Ribeiro da Cunha, Maria, et al.
Publicado: (2021)

Severe ARDS due to Ruxolitinib discontinuation syndrome: case presentation and literature review
por: Houthuys, Jona F., et al.
Publicado: (2022)

A case of trichodysplasia spinulosa related to ruxolitinib treated successfully with oral acitretin
por: Rosa‐Nieves, Priscilla M., et al.
Publicado: (2023)

Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review
por: Sayabovorn, Naruemit, et al.
Publicado: (2021)

Ruxolitinib as Adjunctive Therapy for Hemophagocytic LymPhohistiocytosis after Liver Transplantation: A Case Report and Literature Review
por: He, Kang, et al.
Publicado: (2022)

Ruxolitinib Associated Tuberculosis Presenting as a Neck Lump
por: Shamil, Eamon, et al.
Publicado: (2015)

Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with Ruxolitinib
por: Abidi, Maheen Z., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k693q5o2lqucoea3ln7mrepit8